Developer docs
API playgroundTry for free, no card

Search company profiles

Young & Partners

Full company profile

uuid000owsw

Namestring
Young & Partners
Legal namestring
Young & Partners LLC
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Young & Partners is a boutique investment banking firm founded in 1996 and headquartered at 535 Fifth Avenue, New York, that provides M&A advisory, financial advisory, capital raising, and strategy consulting services exclusively to companies in the chemicals and life sciences sectors — spanning chemicals, pharmaceuticals, biotechnology, medical devices, and CRO/CDMO sub-verticals. The firm is structured as a private LLC, operates with 11–50 employees, and is led by founder Peter Young (President, CEO and Managing Director), with additional senior coverage from Managing Director Stephen Floyd, CMO/Managing Partner Todd Bassett, and dedicated sector author Jonathan Choi. Its revenue model is professional services — primarily transaction-based advisory fees on M&A, divestitures, and capital raises — with no publicly disclosed pricing or revenue figures.

The firm operates a platform-plus-services model in which the core advisory practice is supported by a proprietary content and events infrastructure: recurring bylined analyses published in ICIS Chemical Business, Pharmaceutical Executive, and Chemical Week; three dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com); the Young & Partners Forum webcast; and annual industry events including the Chemical Conference and the Pharmaceutical Executive / Life Science Summit. Geographic reach is anchored in North America, with documented cross-border M&A coverage in Latin America established through a 2011 joint venture with Brazilian investment bank Virtus Br. There is no evidence of proprietary technology products, APIs, or AI/ML capabilities; the firm's differentiation rests on sector specialization, founder-led client relationships, and thought-leadership distribution rather than on technology assets.

Short descriptiontext

Young & Partners is a New York-based boutique investment bank founded in 1996 that provides M&A advisory, financial advisory, capital raising, and strategy consulting exclusively to chemical and life science companies, supported by proprietary trade publications, industry portals, and annual conferences.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment banking advisory, mergers and acquisitions, capital raising services, financial advisory consulting, strategy consulting
Industry4 codes
PRIMARYFSAEAGAJ
Industry-Specialist / Sector-Focused M&A Advisory
SECONDARYFSAEAGAC
Capital Raising Advisory (Equity & Equity-Linked)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYBPAHACAA
Strategy & Corporate Development Consulting
NAICS code2 codes
  • Investment Banking and Securities Intermediation523150
  • Management, Scientific, and Technical Consulting Services5416
SIC code2 codes
  • Security Brokers, Dealers & Flotation Companies6211
  • Services-Management Consulting Services8742
Product category
Specialty Investment Banking Advisory
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Banking Advisory
TypeProfessional Services
Description

M&A advisory, financial advisory, and capital raising services for chemical and life science companies

youngandpartners.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Young & Partners Forum
Description

Webcast and discussion platform hosted by Young & Partners for industry professionals

youngandpartners.com
Core offering1 text field

Young & Partners is a boutique investment bank providing M&A advisory, strategy consulting, financial advisory, and capital raising services to chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. The firm pairs its advisory practice with proprietary industry analyses, annual conferences, and industry portal websites that support client development within the chemical and life science verticals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Young & Partners is a specialized investment banking firm focused on the chemical and life science sectors. The firm operates a platform-plus-services model, offering core M&A advisory, strategy consulting, financial advisory, and capital raising services, complemented by proprietary research publications (Pharmaceutical Executive articles, ICIS Chemical Business analyses, Chemical Week commentary), annual industry conferences (Chemical Conferences, Life Science/Pharmaceutical Executive Summits), and dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com). The publications, conferences, and portals serve as thought leadership and client development tools that support the advisory business.

Product and service1 record
1Investment Banking Advisory Services
CategoryInvestment Banking Advisory
Description

Boutique investment banking offering that includes M&A advisory, strategy consulting, financial advisory, and capital raising services for chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. Engagements are executed directly by senior bankers for corporate executives and owners.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-11-07
Description

Young & Partners entered into a Brazilian cross-border M&A joint venture with Virtus Br, one of the leading Brazilian investment banks, to expand their cross-border Brazilian Mergers and Acquisition Services in Chemicals and Life Sciences. This partnership enabled Young & Partners to better serve clients seeking M&A transactions involving Brazil.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large diversified investment bank with active Healthcare and Specialty Chemicals coverage, providing M&A and capital markets services at a scale that competes against Young & Partners on mid-market mandates.

TypeDirect peer
Description

Middle-market M&A advisory firm with a dedicated Healthcare and Life Sciences practice, comparable boutique positioning serving transaction needs in pharma, biotech, and medical devices.

TypeEmerging player
Description

Specialized pharma and biotech advisory and transaction firm supporting licensing, M&A, and dealmaking, overlapping with Young & Partners' pharmaceutical M&A and capital raising offering.

TypeDirect peer
Description

Specialized life sciences advisory firm offering M&A and strategic partnering services to biopharma and medtech clients, mirroring Young & Partners' boutique life sciences advisory model.

TypeBroad incumbent
Description

Full-service global investment bank with a long-standing specialty in chemicals and life sciences investment banking, offering financing capabilities and equity research Young & Partners cannot match.

TypeDirect peer
Description

Global mid-market investment bank with dedicated Chemicals and Life Sciences practices providing M&A advisory and capital raising - directly comparable boutique-to-mid-market positioning and sector focus to Young & Partners.

TypeDirect peer
Description

Boutique life sciences advisory firm providing strategic and financial advisory to pharma, biotech, and medtech companies - directly comparable specialty M&A positioning on the life sciences side of Young & Partners' practice.

TypeBroad incumbent
Description

Larger global investment bank with active Chemicals and Life Sciences coverage groups providing M&A and capital raising services - overlaps on sector specialization but at materially greater scale and broader product offering.

TypeDirect peer
Description

Middle-market M&A advisor with dedicated Chemicals and Life Sciences groups, comparable in boutique scale and sector specialization for sell-side and buy-side advisory services.

TypeDirect peer
Description

Boutique M&A advisory firm exclusively serving healthcare and life sciences companies, comparable to Young & Partners in scale and sector-specialist positioning on the life sciences side.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Young & Partners

Specialty Investment Banking Advisoryyoungandpartners.com

Young & Partners is a New York-based boutique investment bank founded in 1996 that provides M&A advisory, financial advisory, capital raising, and strategy consulting exclusively to chemical and life science companies, supported by proprietary trade publications, industry portals, and annual conferences.

What Young & Partners does

Young & Partners is a boutique investment banking firm founded in 1996 and headquartered at 535 Fifth Avenue, New York, that provides M&A advisory, financial advisory, capital raising, and strategy consulting services exclusively to companies in the chemicals and life sciences sectors — spanning chemicals, pharmaceuticals, biotechnology, medical devices, and CRO/CDMO sub-verticals. The firm is structured as a private LLC, operates with 11–50 employees, and is led by founder Peter Young (President, CEO and Managing Director), with additional senior coverage from Managing Director Stephen Floyd, CMO/Managing Partner Todd Bassett, and dedicated sector author Jonathan Choi. Its revenue model is professional services — primarily transaction-based advisory fees on M&A, divestitures, and capital raises — with no publicly disclosed pricing or revenue figures.

The firm operates a platform-plus-services model in which the core advisory practice is supported by a proprietary content and events infrastructure: recurring bylined analyses published in ICIS Chemical Business, Pharmaceutical Executive, and Chemical Week; three dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com); the Young & Partners Forum webcast; and annual industry events including the Chemical Conference and the Pharmaceutical Executive / Life Science Summit. Geographic reach is anchored in North America, with documented cross-border M&A coverage in Latin America established through a 2011 joint venture with Brazilian investment bank Virtus Br. There is no evidence of proprietary technology products, APIs, or AI/ML capabilities; the firm's differentiation rests on sector specialization, founder-led client relationships, and thought-leadership distribution rather than on technology assets.

Young & Partners firmographics

Firmographics
Name
Young & Partners
Legal name
Young & Partners LLC
Website
https://youngandpartners.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
Young & Partners is a New York-based boutique investment bank founded in 1996 that provides M&A advisory, financial advisory, capital raising, and strategy consulting exclusively to chemical and life science companies, supported by proprietary trade publications, industry portals, and annual conferences.
Ownership category
akta.pro rank

Young & Partners industry classification

Industry
Product category
Specialty Investment Banking Advisory
NAICS
Investment Banking and Securities Intermediation (523150), Management, Scientific, and Technical Consulting Services (5416)
SIC
Security Brokers, Dealers & Flotation Companies (6211), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYFSAEAGAJ
Industry-Specialist / Sector-Focused M&A Advisory
SECONDARYFSAEAGAC
Capital Raising Advisory (Equity & Equity-Linked)
SECONDARYBPAHADAB
Corporate Finance & Capital Advisory
SECONDARYBPAHACAA
Strategy & Corporate Development Consulting

Keywords

  • Investment banking advisory
  • Mergers and acquisitions
  • Capital raising services
  • Financial advisory consulting
  • Strategy consulting

Where Young & Partners is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Young & Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Investment Banking Advisory: M&A advisory, financial advisory, and capital raising services for chemical and life science companies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Young & Partners product offering

Product offering

Core offering

Young & Partners is a boutique investment bank providing M&A advisory, strategy consulting, financial advisory, and capital raising services to chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. The firm pairs its advisory practice with proprietary industry analyses, annual conferences, and industry portal websites that support client development within the chemical and life science verticals.

Product overview

Young & Partners is a specialized investment banking firm focused on the chemical and life science sectors. The firm operates a platform-plus-services model, offering core M&A advisory, strategy consulting, financial advisory, and capital raising services, complemented by proprietary research publications (Pharmaceutical Executive articles, ICIS Chemical Business analyses, Chemical Week commentary), annual industry conferences (Chemical Conferences, Life Science/Pharmaceutical Executive Summits), and dedicated industry portals (ChemicalIndustry.com, PharmaIndustry.com, MedicalDeviceIndustry.com). The publications, conferences, and portals serve as thought leadership and client development tools that support the advisory business.

Differentiator

Problem solved

Functional benefit

Brands

  • Young & Partners Forum: Webcast and discussion platform hosted by Young & Partners for industry professionals

Products and services

  • Investment Banking Advisory Services Boutique investment banking offering that includes M&A advisory, strategy consulting, financial advisory, and capital raising services for chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. Engagements are executed directly by senior bankers for corporate executives and owners.

Companies that use Young & Partners

Customer profile

Segments2 records

Ideal customer profiles2 records

Young & Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Young & Partners partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Virtus BrcoreStrategic or Co-development Partner · 7 November 2011Young & Partners entered into a Brazilian cross-border M&A joint venture with Virtus Br, one of the leading Brazilian investment banks, to expand their cross-border Brazilian Mergers and Acquisition Services in Chemicals and Life Sciences. This partnership enabled Young & Partners to better serve clients seeking M&A transactions involving Brazil.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Young & Partners competitors and assessment

Company assessment

Broad incumbents

  • Stifel Financial: Large diversified investment bank with active Healthcare and Specialty Chemicals coverage, providing M&A and capital markets services at a scale that competes against Young & Partners on mid-market mandates.
  • Jefferies: Full-service global investment bank with a long-standing specialty in chemicals and life sciences investment banking, offering financing capabilities and equity research Young & Partners cannot match.
  • Houlihan Lokey: Larger global investment bank with active Chemicals and Life Sciences coverage groups providing M&A and capital raising services - overlaps on sector specialization but at materially greater scale and broader product offering.

Direct peers

  • Covington Associates: Middle-market M&A advisory firm with a dedicated Healthcare and Life Sciences practice, comparable boutique positioning serving transaction needs in pharma, biotech, and medical devices.
  • Locust Walk: Specialized life sciences advisory firm offering M&A and strategic partnering services to biopharma and medtech clients, mirroring Young & Partners' boutique life sciences advisory model.
  • Lincoln International: Global mid-market investment bank with dedicated Chemicals and Life Sciences practices providing M&A advisory and capital raising - directly comparable boutique-to-mid-market positioning and sector focus to Young & Partners.
  • Outcome Capital: Boutique life sciences advisory firm providing strategic and financial advisory to pharma, biotech, and medtech companies - directly comparable specialty M&A positioning on the life sciences side of Young & Partners' practice.
  • Harris Williams: Middle-market M&A advisor with dedicated Chemicals and Life Sciences groups, comparable in boutique scale and sector specialization for sell-side and buy-side advisory services.
  • MTS Health Partners: Boutique M&A advisory firm exclusively serving healthcare and life sciences companies, comparable to Young & Partners in scale and sector-specialist positioning on the life sciences side.

Emerging players

  • PharmaVentures: Specialized pharma and biotech advisory and transaction firm supporting licensing, M&A, and dealmaking, overlapping with Young & Partners' pharmaceutical M&A and capital raising offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

Young & Partners social profiles

Digital presence

Young & Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Young & Partners leadership team

Management profile

Number of profiles

Profiles4 records

Young & Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Young & Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Young & Partners

What does Young & Partners do?

Young & Partners is a boutique investment bank providing M&A advisory, strategy consulting, financial advisory, and capital raising services to chemical, pharmaceutical, biotechnology, medical device, and CRO/CDMO companies. The firm pairs its advisory practice with proprietary industry analyses, annual conferences, and industry portal websites that support client development within the chemical and life science verticals.

Is Young & Partners a public or private company?

Young & Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Young & Partners founded?

Young & Partners was founded in 1996. It employs 11 to 50 people.

Where is Young & Partners based?

Young & Partners is headquartered in New York, United States, in the North America region.

How does Young & Partners make money?

One revenue line is on record: investment Banking Advisory.

Who are Young & Partners's main competitors?

Broad incumbents on record are Stifel Financial, Jefferies and Houlihan Lokey. Direct peers are Covington Associates, Locust Walk, Lincoln International, Outcome Capital, Harris Williams and MTS Health Partners. PharmaVentures is listed as an emerging player.

Does Young & Partners have an API?

No public API is recorded for Young & Partners.

What industry is Young & Partners in?

Young & Partners's product category is Specialty Investment Banking Advisory. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of FSAEAGAC, Capital Raising Advisory (Equity & Equity-Linked). Its NAICS code is 523150 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales